90% of liver cancer cases start as chronic liver disease, but most diagnoses are late stage. Watch below to find out how Roche is working with stakeholders to collaborate for change to close the care gap and disrupt the progression of liver disease.

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.